Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
NexImmune, Inc. (NEXI) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/10/2023 8-K Quarterly results
Docs: "NexImmune Reports Second Quarter 2023 Financial Results and Provides Business Updates"
05/18/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
04/26/2023 8-K Quarterly results
04/04/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/04/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/28/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/28/2023 10-K Annual Report for the period ended December 31, 2022
03/28/2023 8-K Quarterly results
03/10/2023 8-K Regulation FD Disclosure  Interactive Data
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
10/28/2022 8-K Quarterly results
08/15/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/15/2022 8-K Quarterly results
07/14/2022 8-K Quarterly results
06/17/2022 8-K Quarterly results
06/17/2022 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
06/14/2022 8-K Quarterly results
05/12/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/12/2022 8-K Quarterly results
05/10/2022 8-K Quarterly results
05/03/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/03/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/14/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "NexImmune Promotes Mathias Oelke, Ph.D., To Chief Scientific Officer"
03/17/2022 8-K Quarterly results
03/09/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/09/2022 S-3 Form S-3 - Registration statement under Securities Act of 1933:
03/09/2022 10-K Annual Report for the period ended December 31, 2021
03/09/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "NexImmune Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Updates"
02/22/2022 SC 13G Brady Louise F. reports a 6.9% stake in NexImmune, Inc.
02/18/2022 SC 13G Long Robert E. Jr. reports a 6.6% stake in NexImmune, Inc.
02/17/2022 8-K Appointed a new director
Docs: "Separation Agreement"
02/14/2022 SC 13G/A ArrowMark Colorado Holdings LLC reports a 7.9% stake in NEXIMMUNE, INC.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy